AI healthcare companies · abridge.com

Abridge valuation, funding and revenue

Abridge sells an AI platform to health systems that turns patient-clinician conversations into clinically useful, billable documentation.

Figures checked September 2026. Each one links to its source.

Latest valuation

$5.3B

April 2026, according to press reports. fortune.com

Total funding

$830M

As of June 2026. fortune.com

Revenue

Not disclosed

Website visits

240K

Estimated, August 2026. -13% on the month before.

What is Abridge's valuation?

Abridge was valued at $5.3B in April 2026, according to press reports (fortune.com). A private company's valuation is set when it raises money, so it can be well out of date between rounds.

How much funding has Abridge raised?

Abridge has raised $830M in total, as of June 2026 (fortune.com). The latest round was a $316M Series E extension in April 2026, according to press reports.

Date	Round	Amount	Led by	Valuation	Source
April 2026	Series E extension	$316M	–	$5.3B	fortune.com (reported)
June 2025	Series E	$300M	Andreessen Horowitz	$5.3B	techcrunch.com (reported)
February 2025	Series D	$250M	Elad Gil, IVP	$2.75B	fortune.com (reported)

What is Abridge's revenue?

Abridge has not published revenue or ARR, and we found no reliable press report of it.

ARR (annual recurring revenue) is the yearly value of current subscriptions; annualized revenue scales a recent month or quarter up to a year. Neither is audited revenue. See what ARR is.

Abridge website traffic

Estimated monthly visits to abridge.com across all channels, rounded. -11% over three months to August 2026.

May 2026270K
June 2026300K
July 2026270K
August 2026240K

Abridge competitors

AI companies in the same category (AI healthcare companies) with a similar amount of website traffic. Similar size and category do not mean identical products; check what each one sells.

Upheal
upheal.io · 350K visits a month
Overjet
overjet.ai · 300K visits a month
Pearl
hellopearl.com · 250K visits a month
Tandem Health
tandemhealth.ai · 170K visits a month
Commure
commure.com · 140K visits a month

Fastest-growing AI healthcare companies

About Abridge

Abridge sells an AI platform to health systems that turns patient-clinician conversations into clinically useful, billable documentation. abridge.com
Founded in 2018. abridge.com
Headquarters: San Francisco, California. abridge.com
Founders: Shiv Rao. abridge.com
The $117 million figure is contracted ARR for Q1 2025 (it includes signed contracts from customers not yet onboarded), reported by TechCrunch citing The Information. It is not realized revenue; the date is the end of Q1 2025. techcrunch.com
Abridge announced the $300 million Series E led by a16z itself but did not state the valuation; the $5.3 billion figure was reported by the Wall Street Journal (via TechCrunch and Axios). abridge.com
The company announced the $250 million Series D (co-led by Elad Gil and IVP) itself; the $2.75 billion post-money valuation comes from Fortune. abridge.com
In June 2026 Abridge announced a strategic investment from Eli Lilly (amount not disclosed) and a foundation-model collaboration with NVIDIA. Fortune reported about $830 million raised to date and a $316 million Series E extension closed in April 2026 at a $5.3 billion valuation; no company announcement of the extension was found. Some aggregator sites cite about $1.1 billion total raised, which could not be confirmed in an allowed source. fortune.com
Abridge reported $117 million in contracted ARR in the first quarter of 2025, a figure that includes customers not yet using the product. techcrunch.com

Get two growing AI companies and two rising searches every Monday.

Free. The paid database tracks every company's traffic, growth and modeled revenue week by week. Compare plans.

Sources

Checked on 29 September 2026. Traffic figures are third-party estimates, not company-reported numbers.